Cytek Biosciences annual gross margin
2020
2021
2022
2023
2024
2025
Cytek Biosciences Gross Margin Growth & History (CTKB)
Cytek Biosciences's gross margin was 51.84% for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 51.84% | −3.58 pp |
| 2024 | 2024-12-31 | 55.43% | −1.27 pp |
| 2023 | 2023-12-31 | 56.69% | −4.86 pp |
| 2022 | 2022-12-31 | 61.56% | −0.30 pp |
| 2021 | 2021-12-31 | 61.86% | +6.16 pp |
| 2020 | 2020-12-31 | 55.70% | — |
Cytek Biosciences quarterly gross margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 58.87% | +6.53 pp |
| Q1 2026 | 2026-03-31 | 48.16% | −0.46 pp |
| Q4 2025 | 2025-12-31 | 52.92% | −5.63 pp |
| Q3 2025 | 2025-09-30 | 52.69% | −3.63 pp |
| Q2 2025 | 2025-06-30 | 52.34% | −2.23 pp |
| Q1 2025 | 2025-03-31 | 48.62% | −2.68 pp |
| Q4 2024 | 2024-12-31 | 58.55% | +1.80 pp |
| Q3 2024 | 2024-09-30 | 56.32% | −0.30 pp |
| Q2 2024 | 2024-06-30 | 54.56% | −2.11 pp |
| Q1 2024 | 2024-03-31 | 51.30% | −5.42 pp |
| Q4 2023 | 2023-12-31 | 56.75% | −4.02 pp |
| Q3 2023 | 2023-09-30 | 56.62% | −9.74 pp |
| Q2 2023 | 2023-06-30 | 56.67% | −4.49 pp |
| Q1 2023 | 2023-03-31 | 56.72% | −0.82 pp |
| Q4 2022 | 2022-12-31 | 60.77% | +0.00 pp |
| Q3 2022 | 2022-09-30 | 66.36% | +4.47 pp |
| Q2 2022 | 2022-06-30 | 61.16% | −3.77 pp |
| Q1 2022 | 2022-03-31 | 57.54% | −2.14 pp |
| Q4 2021 | 2021-12-31 | 60.77% | −1.45 pp |
| Q3 2021 | 2021-09-30 | 61.89% | +18.68 pp |
| Q2 2021 | 2021-06-30 | 64.93% | — |
| Q1 2021 | 2021-03-31 | 59.68% | — |
| Q3 2020 | 2020-09-30 | 62.23% | — |
| Q2 2020 | 2020-06-30 | 43.22% | — |
Cytek Biosciences gross margin trends
Over the last five reported fiscal years, Cytek Biosciences's gross margin decreased from 55.70% to 51.84%, a change of −3.86 percentage points. The latest reported quarter, Q2 2026, shows 58.87%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences filings at SEC.gov ↗